Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V3LR
|
|||
Former ID |
DNC013563
|
|||
Drug Name |
D-166A
|
|||
Synonyms |
D-166A; CHEMBL260151
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C29H34N2O
|
|||
Canonical SMILES |
C1CC(N2CCN(C1C2)CC(CC3=CC=CC=C3)O)C(C4=CC=CC=C4)C5=CC=CC=C5
|
|||
InChI |
1S/C29H34N2O/c32-27(20-23-10-4-1-5-11-23)22-30-18-19-31-21-26(30)16-17-28(31)29(24-12-6-2-7-13-24)25-14-8-3-9-15-25/h1-15,26-29,32H,16-22H2/t26-,27+,28-/m0/s1
|
|||
InChIKey |
WRZZCPUVRXRVCC-IARZGTGTSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Further structural optimization of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine and 1,4-diazabicyclo[3.3.1]nonane derivatives by introducing an ex... Bioorg Med Chem. 2008 Mar 15;16(6):2769-78. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.